A recent review identifies interleukin-36 (IL-36) as a transformative driver of vascular inflammation, revealing that serum ...
Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果